Sionna Therapeutics’ NBD1 stabilisers hold potential to differentiate from Vertex’s existing therapies in cystic fibrosis: GlobalData Read more
Glenmark announces launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial Read more
Nutraceuticals in preventive healthcare: Regulatory advancements and market growth highlighted at ASSOCHAM Summit Read more
EY-Parthenon and Microsoft launch AI framework to guide life sciences sector transformation Read more